CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 5,340	$ 4,181	$ 12,077	$ 10,393
General and administrative	5,374	3,602	10,625	5,177
Total operating expenses	10,714	7,783	22,702	15,570
Loss from operations	10,714	7,783	22,702	15,570
Other income, net:
Interest income	(3,158)	(107)	(6,063)	(110)
Other (income) expense	4	0	6	0
Total other (income) expense, net	(3,154)	(107)	(6,057)	(110)
Net loss	$ 7,560	$ 7,676	$ 16,645	$ 15,460
Net loss per share of common stock, basic	$ (0.19)	$ (1.76)	$ (0.42)	$ (3.58)
Net loss per share of common stock, diluted	$ (0.19)	$ (1.76)	$ (0.42)	$ (3.58)
Weighted-average common stock outstanding, basic	39,570,464	4,361,735	39,504,882	4,321,267
Weighted-average common stock outstanding, diluted	39,570,464	4,361,735	39,504,882	4,321,267